Added to YB: 2023-08-01
Pitch date: 2023-08-01
ESPR [bullish]
Esperion Therapeutics, Inc.
+115.95%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.
Market Cap
$807.5M
Pitch Price
$1.63
Price Target
N/A
Dividend
N/A
EV/EBITDA
-53.12
P/E
-6.40
EV/Sales
4.33
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Esperion Therapeutics: Litigation Special Situation, Potential Blockbuster Drug
A summary for this pitch has not been created yet.
Read full article (1 min)